Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:05 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Oxytocin in MRI-HIFU

ClinicalTrials.gov · NCT03937401 · Registry updated: 2019-05-03

Condition / research focus: Fibroid; Adenomyosis
Sponsor: Turku University Hospital
Countries with listed sites: Finland
Registry dates and results: Start: 2019-02-01. Completion: 2021-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: MRI-HIFU

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Turku University Hospital
Turku, Finland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Induction of Labor With Oxytocin: When Should Oxytocin be Held?

ClinicalTrials.gov · NCT00957593 · Registry updated: 2019-04-23

Condition / research focus: Labor Induction; Cesarean Delivery
Sponsor: Lehigh Valley Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2009-02. Completion: 2011-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin discontinuation (drug)

Where the study takes place — 1 listed sites

Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity

ClinicalTrials.gov · NCT03829839 · Registry updated: 2019-04-17

Condition / research focus: Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2016-03-03. Completion: 2017-08-16 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon
Lorazepam 1 mg (drug) — also listed as: Tavor
Placebo nasalspray (drug)
Placebo Oral Tablet (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Influence of Intranasal Oxytocin on Communication

ClinicalTrials.gov · NCT02415920 · Registry updated: 2019-04-17

Condition / research focus: Healthy
Sponsor: University of British Columbia
Countries with listed sites: Canada
Registry dates and results: Start: 2017-11-06. Completion: 2018-12-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Kenny Psychology Building
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1WithdrawnINTERVENTIONAL

Oxytocin in Alcohol Use Disorder

ClinicalTrials.gov · NCT02711189 · Registry updated: 2019-04-11

Condition / research focus: Alcoholism
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-03-08. Completion: 2019-02-22 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women

ClinicalTrials.gov · NCT01513499 · Registry updated: 2019-04-08

Condition / research focus: Eating Behavior
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2012-01. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon (Novartis)
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Oxytocin Effects on Food Motivation Pathways

ClinicalTrials.gov · NCT02276677 · Registry updated: 2019-04-08

Condition / research focus: Overweight and Obesity
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2014-10. Completion: 2015-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section

ClinicalTrials.gov · NCT00107874 · Registry updated: 2019-04-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 1999-01. Completion: 2002-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (drug)

Where the study takes place — 1 listed sites

Women's University Hospital, Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Neural Account of Social Placebo Effect

ClinicalTrials.gov · NCT03891459 · Registry updated: 2019-03-27

Condition / research focus: Spray+ Group; Control Group
Sponsor: Beijing Normal University
Countries with listed sites: China
Registry dates and results: Start: 2018-06-27. Completion: 2018-11-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

spray+ manipulation (behavioral)
control manipulation (behavioral)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Dopamine's Effect on Vicarious Optimism

ClinicalTrials.gov · NCT03891095 · Registry updated: 2019-03-26

Condition / research focus: Oxytocin Group; L-DOPA Group; Placebo Group
Sponsor: Beijing Normal University
Countries with listed sites: China
Registry dates and results: Start: 2018-12-01. Completion: 2019-01-16 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
L-DOPA (drug)
Placebos (drug)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Premature Rupture of Membranes at 34 to 37 Weeks' Gestation

ClinicalTrials.gov · NCT03689062 · Registry updated: 2019-03-25

Condition / research focus: Premature Rupture of Membrane
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-05. Completion: 2020-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

induction of labor (procedure)
follow up (procedure)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

ClinicalTrials.gov · NCT02058251 · Registry updated: 2019-03-14

Condition / research focus: Alcohol Use Disorders
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2014-02. Completion: 2017-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin in Cocaine Dependence

ClinicalTrials.gov · NCT01573273 · Registry updated: 2019-03-13

Condition / research focus: Cocaine Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2017-12-19 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Saline (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section

ClinicalTrials.gov · NCT03591679 · Registry updated: 2019-03-11

Condition / research focus: Post Partum Hemorrhage
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-12-01. Completion: 2019-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
bilateral uterine artery ligation (procedure)

Where the study takes place — 1 listed sites

Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours

ClinicalTrials.gov · NCT03045939 · Registry updated: 2019-03-05

Condition / research focus: Induction of Labor; Unfavorable Cervix
Sponsor: Bnai Zion Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2017-03-01. Completion: 2019-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical ripening device (device) — also listed as: atad double balloon device

Where the study takes place — 1 listed sites

Bnai Zion Mc
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin HIV Meth Study

ClinicalTrials.gov · NCT02881177 · Registry updated: 2019-03-05

Condition / research focus: Amphetamine Use Disorders
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2017-01. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug) — also listed as: Saline

Where the study takes place — 1 listed sites

University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour

ClinicalTrials.gov · NCT01587625 · Registry updated: 2019-03-04

Condition / research focus: Birth; Delayed
Sponsor: Göteborg University
Countries with listed sites: Sweden
Registry dates and results: Start: 2013-08. Completion: 2016-10-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 2 listed sites

Sahlgrenska University Hospital
Gothenburg, Sweden
Site recruitment: Not reported
NU Hospital Group
Trollhättan, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin Effect on Attention Inhibition

ClinicalTrials.gov · NCT03486925 · Registry updated: 2019-03-04

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-12-19. Completion: 2018-08-28 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin treatment (drug)
placebo treatment (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Dose-dependent Effects of Oxytocin on the Amygdala and Reward System

ClinicalTrials.gov · NCT03846739 · Registry updated: 2019-02-28

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2017-04-03. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2WithdrawnINTERVENTIONAL

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

ClinicalTrials.gov · NCT00315913 · Registry updated: 2019-02-27

Condition / research focus: Dysfunctional Labor
Sponsor: University of California, Irvine
Countries with listed sites: United States
Registry dates and results: Start: 2004-01. Completion: 2008-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propranolol (drug) — also listed as: Inderal
IV Placebo (other) — also listed as: Normal Saline

Where the study takes place — 1 listed sites

Long Beach Memorial Medical Center
Long Beach, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:05 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Oxytocin in MRI-HIFU

ClinicalTrials.gov · NCT03937401 · Registry updated: 2019-05-03

Condition / research focus: Fibroid; Adenomyosis
Sponsor: Turku University Hospital
Countries with listed sites: Finland
Registry dates and results: Start: 2019-02-01. Completion: 2021-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: MRI-HIFU

Where the study takes place — 1 listed sites

Turku University Hospital
Turku, Finland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Induction of Labor With Oxytocin: When Should Oxytocin be Held?

ClinicalTrials.gov · NCT00957593 · Registry updated: 2019-04-23

Condition / research focus: Labor Induction; Cesarean Delivery
Sponsor: Lehigh Valley Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2009-02. Completion: 2011-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin discontinuation (drug)

Where the study takes place — 1 listed sites

Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity

ClinicalTrials.gov · NCT03829839 · Registry updated: 2019-04-17

Condition / research focus: Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2016-03-03. Completion: 2017-08-16 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon
Lorazepam 1 mg (drug) — also listed as: Tavor
Placebo nasalspray (drug)
Placebo Oral Tablet (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Influence of Intranasal Oxytocin on Communication

ClinicalTrials.gov · NCT02415920 · Registry updated: 2019-04-17

Condition / research focus: Healthy
Sponsor: University of British Columbia
Countries with listed sites: Canada
Registry dates and results: Start: 2017-11-06. Completion: 2018-12-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Kenny Psychology Building
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1WithdrawnINTERVENTIONAL

Oxytocin in Alcohol Use Disorder

ClinicalTrials.gov · NCT02711189 · Registry updated: 2019-04-11

Condition / research focus: Alcoholism
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-03-08. Completion: 2019-02-22 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women

ClinicalTrials.gov · NCT01513499 · Registry updated: 2019-04-08

Condition / research focus: Eating Behavior
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2012-01. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon (Novartis)
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Oxytocin Effects on Food Motivation Pathways

ClinicalTrials.gov · NCT02276677 · Registry updated: 2019-04-08

Condition / research focus: Overweight and Obesity
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2014-10. Completion: 2015-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section

ClinicalTrials.gov · NCT00107874 · Registry updated: 2019-04-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 1999-01. Completion: 2002-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (drug)

Where the study takes place — 1 listed sites

Women's University Hospital, Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Neural Account of Social Placebo Effect

ClinicalTrials.gov · NCT03891459 · Registry updated: 2019-03-27

Condition / research focus: Spray+ Group; Control Group
Sponsor: Beijing Normal University
Countries with listed sites: China
Registry dates and results: Start: 2018-06-27. Completion: 2018-11-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

spray+ manipulation (behavioral)
control manipulation (behavioral)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Dopamine's Effect on Vicarious Optimism

ClinicalTrials.gov · NCT03891095 · Registry updated: 2019-03-26

Condition / research focus: Oxytocin Group; L-DOPA Group; Placebo Group
Sponsor: Beijing Normal University
Countries with listed sites: China
Registry dates and results: Start: 2018-12-01. Completion: 2019-01-16 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
L-DOPA (drug)
Placebos (drug)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Premature Rupture of Membranes at 34 to 37 Weeks' Gestation

ClinicalTrials.gov · NCT03689062 · Registry updated: 2019-03-25

Condition / research focus: Premature Rupture of Membrane
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-05. Completion: 2020-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

induction of labor (procedure)
follow up (procedure)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

ClinicalTrials.gov · NCT02058251 · Registry updated: 2019-03-14

Condition / research focus: Alcohol Use Disorders
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2014-02. Completion: 2017-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin in Cocaine Dependence

ClinicalTrials.gov · NCT01573273 · Registry updated: 2019-03-13

Condition / research focus: Cocaine Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2017-12-19 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Saline (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section

ClinicalTrials.gov · NCT03591679 · Registry updated: 2019-03-11

Condition / research focus: Post Partum Hemorrhage
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-12-01. Completion: 2019-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
bilateral uterine artery ligation (procedure)

Where the study takes place — 1 listed sites

Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours

ClinicalTrials.gov · NCT03045939 · Registry updated: 2019-03-05

Condition / research focus: Induction of Labor; Unfavorable Cervix
Sponsor: Bnai Zion Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2017-03-01. Completion: 2019-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical ripening device (device) — also listed as: atad double balloon device

Where the study takes place — 1 listed sites

Bnai Zion Mc
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin HIV Meth Study

ClinicalTrials.gov · NCT02881177 · Registry updated: 2019-03-05

Condition / research focus: Amphetamine Use Disorders
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2017-01. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug) — also listed as: Saline

Where the study takes place — 1 listed sites

University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour

ClinicalTrials.gov · NCT01587625 · Registry updated: 2019-03-04

Condition / research focus: Birth; Delayed
Sponsor: Göteborg University
Countries with listed sites: Sweden
Registry dates and results: Start: 2013-08. Completion: 2016-10-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 2 listed sites

Sahlgrenska University Hospital
Gothenburg, Sweden
Site recruitment: Not reported
NU Hospital Group
Trollhättan, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin Effect on Attention Inhibition

ClinicalTrials.gov · NCT03486925 · Registry updated: 2019-03-04

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-12-19. Completion: 2018-08-28 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin treatment (drug)
placebo treatment (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Dose-dependent Effects of Oxytocin on the Amygdala and Reward System

ClinicalTrials.gov · NCT03846739 · Registry updated: 2019-02-28

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2017-04-03. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2WithdrawnINTERVENTIONAL

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

ClinicalTrials.gov · NCT00315913 · Registry updated: 2019-02-27

Condition / research focus: Dysfunctional Labor
Sponsor: University of California, Irvine
Countries with listed sites: United States
Registry dates and results: Start: 2004-01. Completion: 2008-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propranolol (drug) — also listed as: Inderal
IV Placebo (other) — also listed as: Normal Saline

Where the study takes place — 1 listed sites

Long Beach Memorial Medical Center
Long Beach, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →